US PTAB IP Litigation
5,620 annotated decisions
Page 147 of 235 · 5,620 total
patent null · Sep 2, 2024
Dexcom, Inc. v.Abbott Diabetes Care Inc.
· IPR2024-00521
Dexcom, Inc. filed a Petition challenging claims 1, 13, and 29 of Abbott Diabetes Care Inc.'s patent (US 11298056). The challenger asserts that these claims are obvious under 35 U.S.C. § 103 based on combinations of prior art references like Patel-2009 and Paradigm® REAL-Time. This petition also argues against discretionary denial, asserting the arguments are new and diligent.
patent instituted · Sep 2, 2024
Juniper Networks, Inc v.Monarch Networking Solutions LLC
· IPR2024-00565
Juniper Networks successfully petitioned to challenge Monarch Networking Solutions' patent on grounds of obviousness (35 U.S.C. § 103). The Board found a reasonable likelihood of success, leading to the institution of the IPR proceedings against claims 1 and 5-8.
patent denied · Sep 2, 2024
DISH Network L.L.C. et al. v.Entropic Communications LLC
· IPR2024-00562
DISH Network L.L.C.'s attempt to invalidate 40 claims of Entropic Communications' patent (8363681) was denied by the PTAB. The Board found insufficient evidence that the claimed clock synchronization methods were obvious over prior art, including IEEE802.3ah and Shvodian.
patent denied · Sep 2, 2024
DISH Network L.L.C. et al. v.Entropic Communications LLC
· IPR2024-00560
The PTAB denied institution of IPR for DISH Network against Entropic Communications, finding that the challenger failed to establish a reasonable likelihood of prevailing on grounds of obviousness. The challenge related to common bit-loading methods in broadband coaxial networks.
patent instituted · Sep 2, 2024
Microsoft Corporation et al. v.InterDigital Patent Holdings, Inc. et al.
· IPR2024-00538
Microsoft Corporation successfully challenged InterDigital Patent Holdings, Inc.'s patent claims in a PTAB decision. The Board found that the petitioner demonstrated a reasonable likelihood of prevailing on all asserted grounds regarding anticipation and obviousness. This institution decision keeps the dispute alive for further review.
patent final · Sep 2, 2024
Microsoft Corporation et al. v.InterDigital Patent Holdings, Inc. et al.
· IPR2024-00538
The Board upheld the validity of patent 9173054 after finding that the priority date (December 22, 2009) disqualified all cited prior art under Sections 102 and 103. The Patent Owner successfully argued that the ancestor application sufficiently described both Bluetooth detection and Wi-Fi data transfer methods.
patent · Sep 1, 2024
TransCore LP v.Hand Held Products, Inc.
· IPR2024-00391
Hand Held Products argues that TransCore's IPR petition fails because the cited Katz reference is not a printed publication and the petitioner’s reliance on Tolonen and Ishizu lacks the required particularity. The owner seeks denial of institution and invokes §325(d).
patent terminated or settled · Sep 1, 2024
TransCore LP v.Hand Held Products, Inc.
· IPR2024-00391
TransCore and Hand Held Products entered a settlement that resolved all disputes over three patents. The parties jointly moved to terminate the IPRs, and the Board granted the termination and kept the settlement confidential.
patent terminated or settled · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
EndyMed Medical and Serendia settled their inter partes review disputes over U.S. Patent 9,775,774, leading the PTAB to terminate the proceedings and keep the settlement confidential.
patent · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
Serendia requests the USPTO Director to vacate the institution of an IPR against its dermatology device patent after the ITC upheld the patent’s validity, arguing the Board abused discretion and that the Fintiv factors favor denial.
patent terminated or settled · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
The PTAB granted a settlement‑based termination for Jeisys Medical in three IPRs while allowing the proceedings to continue for EndyMed. The settlement agreement was ordered to be kept confidential.
patent · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
Jeisys Medical and Serendia have filed a joint request in IPR2024-00383 to keep their settlement agreement confidential under 35 U.S.C. § 317(b). The parties seek to have the agreement treated as business confidential information and kept separate from the patent file.
patent · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
During an IPR hearing, Jeisys Medical announced a settlement with SHEnB and Cartessa respondents, seeking to suspend the schedule until November 20.
patent terminated or settled · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
Jeisys Medical and Serendia settled their IPR dispute over U.S. Patent 9,775,774 and jointly moved to terminate the proceeding.
patent · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
Court decision.
patent terminated or settled · Sep 1, 2024
TransCore LP v.Hand Held Products, Inc.
· IPR2024-00391
TransCore and Hand Held Products entered a confidential settlement and jointly moved to terminate IPR2024-00391 concerning U.S. Patent 8,141,784. The Board has not yet decided the merits, and the parties request termination to conserve resources.
patent · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
EndyMed Medical and Serendia have filed a joint request to keep their settlement agreement confidential under statutory provisions, separating it from the patent record.
patent null · Sep 1, 2024
TransCore LP v.Hand Held Products, Inc.
· IPR2024-00391
TransCore LP challenges U.S. Patent No. 8,141,784 in the PTAB, asserting that the claims are unpatentable over prior art references Tolonen and Katz. The petitioner argues that the core features of the patent—such as EIR terminals connecting chipsets to baseband software—are anticipated or obvious based on these older technologies.
patent null · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
Jeisys Medical Inc. challenged Serendia, LLC's '774 patent in an IPR petition, asserting that claims are anticipated by Mehta and rendered obvious through combinations involving Na ’848 and Lee. The petition focuses on the unpatentability of medical device claims related to dermatological treatment/microneedling.
patent instituted · Sep 1, 2024
Jeisys Medical Inc. et al. v.Serendia, LLC
· IPR2024-00383
The PTAB instituted an IPR challenging claims 13 and 14 of Serendia's patent, finding a reasonable likelihood of anticipation by the prior art reference Mehta. The case moves to trial phase after rejecting arguments for discretionary denial based on competitor relationships.
patent some challenged claims unpatentable · Aug 30, 2024
Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.
· PGR2024-00050
The PTAB issued a Final Written Decision in PGR2024‑00050, finding claims 5 and 17 indefinite and lacking written description, and deeming claims 1‑12, 15‑17, and 21‑23 obvious over Gilb ’792 and Bundy. The Board granted a partial amendment for claim 32 while denying other proposed substitute claims.
patent mixed - some claims cancelled, some upheld · Aug 30, 2024
Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.
· PGR2024-00050
The PTAB found 103 of the 105 claims of Simpson Strong‑Tie’s fire‑wall hanger patent unpatentable as obvious over a combination of Yamaguchi, Bundy, Adams and Gilb ’416 references. Claims 38 and 91 were left intact. The Board adopted petitioner‑proposed claim constructions.
patent · Aug 30, 2024
Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.
· PGR2024-00050
Simpson Strong‑Tie challenges Columbia Insurance’s post‑grant review of U.S. Patent 11,920,339 covering fire‑wall hanger systems. The patent owner’s sur‑reply argues the petition’s obviousness and written‑description attacks fail, emphasizing strong secondary‑consideration evidence. The case remains pending before the PTAB.
patent · Aug 30, 2024
Simpson Strong-Tie Company Inc. et al. v.Columbia Insurance Company et al.
· PGR2024-00050
Simpson Strong‑Tie and Columbia Insurance have settled their dispute over U.S. Patent 11,920,339 and jointly filed a request to keep the settlement agreement confidential while moving to terminate the post‑grant review.
